» Authors » Yasuko Matsuo

Yasuko Matsuo

Explore the profile of Yasuko Matsuo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 105
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Doi S, Yasuda S, Miyashita M, Nagai M, Nakamura K, Matsuo Y, et al.
Ann Gastroenterol Surg . 2025 Mar; 9(2):359-368. PMID: 40046516
Aim: The relationship between sarcopenia, tumor-infiltrating lymphocytes (TILs), and long-term survival in patients with hepatocellular carcinoma (HCC) has not been investigated. We aimed to evaluate the prognostic relevance of sarcopenia...
2.
Nakahara H, Doi S, Yasuda S, Nagai M, Nakamura K, Matsuo Y, et al.
J Surg Case Rep . 2025 Mar; 2025(2):rjaf098. PMID: 40040766
Management of gastrointestinal perforation in patients with vascular Ehlers-Danlos syndrome (vEDS) is clinically challenging. A male in his 40s with vEDS presented with right lower abdominal pain. Computed tomography revealed...
3.
Kosai-Fujimoto Y, Yoh T, Hara T, Umezawa S, Maekawa A, Matsuo Y, et al.
J Hepatobiliary Pancreat Sci . 2024 Dec; 32(1):17-25. PMID: 39655474
A questionnaire survey was designed and performed to assess the current status of "next generation" hepatobiliary and pancreatic (HBP) surgeons regarding surgical training, career, recruiting, and work-life balance in Japan....
4.
Kohara Y, Yasuda S, Nagai M, Nakamura K, Matsuo Y, Terai T, et al.
J Hepatobiliary Pancreat Sci . 2024 Nov; 31(12):906-916. PMID: 39489619
Background: Creatine kinase (CK) levels decrease with cancer progression and muscle wasting, but its association with pancreatic ductal adenocarcinoma (PDAC) remains unclear. The aim of this study was to investigate...
5.
Kinoshita S, Terai T, Nagai M, Nakamura K, Kohara Y, Yasuda S, et al.
Pancreatology . 2024 Oct; 24(8):1280-1287. PMID: 39419752
Background: CD200, a negative regulator of T cells as well as a marker for cancer stem cells, represents a significant prognostic factor and potential therapeutic target in certain cancers. However,...
6.
Doi S, Yasuda S, Nagai M, Nakamura K, Matsuo Y, Terai T, et al.
Hepatol Res . 2024 Oct; PMID: 39365148
Aim: Persistent acute kidney injury (AKI) has not been investigated in patients undergoing liver resection. We aimed to identify the predictors of persistent AKI, its effect on postoperative outcomes and...
7.
Yasuda S, Matsuo Y, Doi S, Sakata T, Nagai M, Nakamura K, et al.
Langenbecks Arch Surg . 2024 Sep; 409(1):283. PMID: 39292284
Purpose: Hepatocellular carcinoma (HCC) patients beyond the Milan criteria (MC) who undergo liver resection have high recurrence rates and poor prognosis, and sometimes experience very early recurrence (VER) within six...
8.
Terai T, Nishiwada S, Nagai M, Nakamura K, Kohara Y, Yasuda S, et al.
Pancreatology . 2024 Aug; 24(6):938-946. PMID: 39152081
Background: PDAC cells upregulate carbonic anhydrase 9 (CA9) expression in order to survive in hypoxic tumor environments, which plays a key role in tumor progression. However, the relationship between CA9...
9.
Kohara Y, Yasuda S, Nagai M, Nakamura K, Matsuo Y, Terai T, et al.
Ann Surg Oncol . 2024 Aug; 31(12):7713-7721. PMID: 39107610
Background: Hyperglycemia is involved in malignant transformation of pancreatic cancer via the hexosamine biosynthetic pathway (HBP). However, few studies have verified this mechanism based on clinical data. This study investigated...
10.
Uchiyama C, Terai T, Nagai M, Nakamura K, Kohara Y, Yasuda S, et al.
Pancreatology . 2024 Aug; 24(6):925-929. PMID: 39103254
Background: The management of malignant ascites is critical for treating patients with advanced pancreatic cancer. The purpose of this study was to assess the safety of cell-free and concentrated ascites...